LBH589 Treatment for Refractory Clear Cell Renal Carcinoma

Clinical trial NCT00550277 · COMPLETED

Trial details

NCT number: NCT00550277
Sponsor: SCRI Development Innovations, LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Renal Cell Carcinoma

Start date: 2008-01-01
Primary completion: 2010-03-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.